Ireland - English - HPRA (Health Products Regulatory Authority)

merus labs luxco ii s.à.r.l. - isosorbide dinitrate - concentrate for solution for infusion - 0.1 percent weight/volume - organic nitrates; isosorbide dinitrate

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - tadalafil - hypertension, pulmonary - urologicals - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5.1).efficacy has been shown in idiopathic pah (ipah) and in pah related to collagen vascular disease.paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.

European Union - English - EMA (European Medicines Agency)

bayer ag  - vardenafil - erectile dysfunction - urologicals - treatment of erectile dysfunction in adult men.erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.in order for levitra to be effective, sexual stimulation is required.levitra is not indicated for use by women.

European Union - English - EMA (European Medicines Agency)

bayer ag  - vardenafil - erectile dysfunction - urologicals - treatment of erectile dysfunction in adult men. erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.in order for vivanza to be effective, sexual stimulation is required.vivanza is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - sildenafil citrate, quantity: 35.1 mg (equivalent: sildenafil, qty 25 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; magnesium stearate; copovidone; microcrystalline cellulose; saccharin sodium; calcium hydrogen phosphate; croscarmellose sodium - noumed sildenafil is indicated for the treatment of erectile dysfunction in adult males. noumed sildenafil is not indicated for use by women.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 0.1 mg in 1 h - transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack. nitroglycerin is contraindicated in patients who are allergic to it. allergy to the adhesives used in nitroglycerin patches has also been reported, and it similarly constitutes a contraindication to the use of this product. do not use nitroglycerin transdermal systems in patients who are taking phosphodiesterase inhibitors (such as sildenafil, tadalafil, or vardenafil) for erectile dysfunction or pulmonary arterial hypertension. concomitant use can cause severe drops in blood pressure. do not use nitroglycerin transdermal systems in patients who are taking the soluble guanylate cyclase stimulator riociguat. concomitant use can cause hypotension.

United States - English - NLM (National Library of Medicine)

alvogen, inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 0.1 mg in 1 h - transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack. nitroglycerin is contraindicated in patients who are allergic to it. allergy to the adhesives used in nitroglycerin patches has also been reported, and it similarly constitutes a contraindication to the use of this product. do not use nitroglycerin transdermal infusion system in patients who are taking phosphodiesterase inhibitors (such as sildenafil, tadalafil, or vardenafil) for erectile dysfunction or pulmonary arterial hypertension. concomitant use can cause severe drops in blood pressure. do not use nitroglycerin transdermal infusion system in patients who are taking the soluble guanylate cyclase stimulator riociguat. concomitant use can cause hypotension.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sildenafil citrate -

Malta - English - Medicines Authority

pls pharma - produtos farmacêuti, lda estrada de paço de arcos, edifício espaço, nº 9 – 2f, 2770-218, paço de arcos, portugal - concentrate for solution for infusion or injection - isosorbide dinitrate 1 mg/ml - cardiac therapy